|
HS Code |
872361 |
| Chemical Name | 2-Bromo-N,N-Dimethylacetamide |
| Cas Number | 2845-89-8 |
| Molecular Formula | C4H8BrNO |
| Molecular Weight | 166.02 g/mol |
| Appearance | Clear colorless to pale yellow liquid |
| Boiling Point | 78-80°C at 7 mmHg |
| Density | 1.487 g/cm3 at 25°C |
| Refractive Index | 1.481 |
| Solubility | Soluble in water and common organic solvents |
| Purity | Typically ≥98% |
| Synonyms | N,N-Dimethyl-2-bromoacetamide |
As an accredited 2-Bromo-N,N-Dimethylacetamide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Bromo-N,N-Dimethylacetamide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemistry shapes nearly every corner of our daily lives, yet most of us never realize where it’s working behind the scenes. Take laboratory breakthroughs in pharmaceuticals, specialty materials, and advanced electronics—for many of these advances, the work begins with specialty chemicals. One compound quietly making a mark belongs to the family of acetamides: 2-Bromo-N,N-Dimethylacetamide. For folks spending long hours at the lab bench or on the production floor, selecting the right reagent can make all the difference between a successful synthesis and a frustrating afternoon. Let’s take a look at what sets 2-Bromo-N,N-Dimethylacetamide apart, how it’s typically used, and why it’s worth attention from researchers and industry professionals who care about quality and reliability.
2-Bromo-N,N-Dimethylacetamide has a chemical structure that places a bromine atom at the two-position of a dimethylacetamide framework. This subtle twist might sound minor, but in the complex world of chemical reactions, even a slight molecular shift can turn an ordinary process into an opportunity for innovation. The presence of both the bromine and the dimethyl groups creates specific reactive features, making it more selective in certain reactions compared to standard acetamides. Synthetic chemists appreciate these fine details because they allow for more precise control over the outcome of their reactions, reducing byproduct formation and increasing yield. The physical appearance matches that of many lab solvents and reagents: it’s usually a clear to very pale fluid, which makes it easy to use in routine benchwork without dealing with stubborn crystals or insoluble powders.
Chemists working in research or pharmaceutical sectors often run into the problem of limited starting materials—running reactions with complex reagents can waste time and money if things go off track. 2-Bromo-N,N-Dimethylacetamide offers an edge in these scenarios. Its reactivity is tuned to provide better selectivity for specific transformations, especially in the creation of intermediate building blocks for medicinal chemistry. Many contemporary drug candidates depend on efficient, safe, and scalable transformations, and the bromine group plays a helpful part by enabling substitution or coupling reactions. Over the years, some of the most stubborn synthetic challenges I’ve faced have involved chemoselectivity—shuffling functional groups around without wrecking the rest of the molecule. The niche filled by this compound isn’t about replacing every acetamide, but about offering a smoother route for tricky modifications that other reagents can’t always handle.
Of course, the story doesn’t end with pharma. The electronics world, which relies on advanced organic compounds for everything from OLED displays to photovoltaics, has found unique uses for halogenated acetamide derivatives. The tailored reactivity offered by 2-Bromo-N,N-Dimethylacetamide often leads to new downstream materials with tailored electrical or optical properties. These advances sound futuristic, but they’re arriving on store shelves every year, translating to sharper screens and longer-lasting devices for everyone.
Most research chemists know that product quality hinges on purity. Tiny impurities can destroy yields, block reaction pathways, or even introduce toxic elements into a drug or material. High-purity 2-Bromo-N,N-Dimethylacetamide stands out in this respect. Reliable suppliers will certify purity at levels above 98 or 99 percent, which goes beyond marketing fluff and becomes an everyday concern. I’ve seen students struggle with “good enough” chemicals, only to chase their tails over puzzling side products that never show up in reference articles. The best results come from starting with the cleanest possible inputs, especially when the stakes include clinical safety or final product performance.
Subtle handling details sometimes get lost in translation between research papers and production scale work. Thankfully, 2-Bromo-N,N-Dimethylacetamide brings a straightforward liquid profile—no need for lengthy dissolving steps or temperature treatments just to make up a standard stock solution. A straightforward density and moderate viscosity mean it integrates into existing workflows with ease. Unlike some alternatives that demand precise temperature or humidity controls during storage, this compound keeps well under basic dry, cool conditions. Spill risks are also manageable, which is something every lab manager values. For scale-up or industrial use, this hassle-free storage and transfer really lowers the chances of lost batches or contaminated lines, saving both time and headaches.
Sometimes it’s easier to see what makes a product special by holding it up beside its cousins. Take standard N,N-dimethylacetamide, a common lab solvent and amidation agent. The molecular similarity to our compound means both are used in synthesis, but the bromine group on the 2-position gives 2-Bromo-N,N-Dimethylacetamide a much greater range of reactivity with nucleophiles and organometallic reagents. For certain substitutions or cross-couplings, this difference translates to higher yields and milder conditions—not just a win for the bottom line, but also for sustainability and worker safety.
Looking at alternatives, several halogenated acetamides compete for the same roles. Chlorinated variants, for example, often bring higher reactivity but tend to generate harsh byproducts and have a nastier safety profile, particularly concerning volatility and toxicity. The brominated version strikes a middle ground, maintaining effective reactivity while side-stepping some of the cleanup and waste disposal headaches attached to harsher halogens. This feature directly impacts lab safety protocols, waste stream costs, and environmental stewardship criteria, which have all become more important in modern laboratory and factory environments.
Broad shifts in regulations and consumer demand are driving industries away from outdated reagents toward those with a better safety record or more predictable behavior. If you work in regulated spaces—say, developing a new pharmaceutical for FDA review or sourcing raw materials for an ISO-certified electronics facility—reagent traceability and compliance documentation often become as important as synthetic yield. 2-Bromo-N,N-Dimethylacetamide now appears on more approved lists for these purposes because regulatory data shows it leaves fewer persistent toxins or long-chain byproducts behind. Environmental, Health, and Safety (EHS) managers appreciate this trend. Over time, as stricter rules shape what qualifies for large-scale production, products with cleaner safety records will only rise in popularity.
Speaking from experience, small changes in the supply roster can disrupt months of development if a replacement proves less reliable or more troublesome. When a compound consistently performs according to published data, can be sourced with reliable paperwork, and won’t bring down the wrath of a surprise audit, that’s a genuine asset. The continuing rise in popularity for this acetamide derivative fits with conversations I’ve had in industry roundtables: companies are consolidating around fewer, proven reagents that deliver both technical results and compliance peace of mind.
Scientific literature over the last decade has increasingly called out 2-Bromo-N,N-Dimethylacetamide for both niche synthetic routes and as a transitional intermediate in the preparation of farmaceutical precursors, agrochemical candidates, and specialty dyes. Case studies from academic research point toward specific reaction protocols—such as C-N bond coupling and novel cross-linking reactions—where this compound’s unique combination of steric and electronic features delivers better selectivity than other brominated or unsubstituted amides. Researchers in organometallic chemistry have highlighted its usefulness in the formation of complex frameworks, pointing to its ability to act as either a substrate or a strategic blocking agent. These details matter to process buyers at pharmaceutical firms or advanced materials manufacturers who want a reagent that serves multiple purposes while lowering inventory complexity.
Outside of academic or high-tech settings, regulatory and environmental scientists are paying more attention to how production-scale use of chemicals tracks with regional waste and emission codes. Unlike some traditional halogenated aromatics or volatile methylating agents, 2-Bromo-N,N-Dimethylacetamide’s breakdown products fit better with both U.S. EPA and EU REACH standards. When planning ahead for audits or production launches, having a reagent with a well-documented safety and fate profile makes life easier. Scarcity of established regulatory hurdles lowers the startup barrier for small firms or university labs moving an idea from bench to pilot scale.
Every chemical has tradeoffs, and safety remains a top concern. 2-Bromo-N,N-Dimethylacetamide hasn’t escaped scrutiny; bromine compounds historically draw extra questions about long-term health and environmental outcomes. Recent reviews show that this compound, while reactive, doesn’t pose the same volatility or acute toxicity risks associated with older halogenated solvents. Still, users should always handle it with gloves, eye protection, and work in properly ventilated spaces. Special care during transfer and waste disposal responsible handling remains a priority. Having handled sensitive and reactive chemicals for years, I always advise keeping up with current training and best practices, even for compounds with a reliable safety record. A safe lab is a productive lab, and small lapses lead to big problems. Reliable suppliers back up their shipments with transparent safety sheets and, increasingly, origin and transport chain records to assure buyers of both product integrity and responsible manufacturing.
With climate and sustainability on everyone’s minds these days, the push for chemical reagents with smaller footprints is picking up speed. 2-Bromo-N,N-Dimethylacetamide belongs to a class of compounds being revisited under “green chemistry” criteria. Nearly every academic and industrial chemistry journal now features sections covering life-cycle analysis, end-of-life breakdown, or comparative waste generation. Niche advantages—such as reduced side-reactions and cleaner byproduct streams—turn out to be surprisingly important when calculated at scale. If a kilogram-scale process results in hundreds fewer liters of halogenated waste, that savings manifests in both regulatory paperwork and real environmental benefits. Forward-thinking chemical manufacturers now use this data in design and scale-up meetings.
Some companies have begun blending new catalysts and synthesis protocols specifically to pair with 2-Bromo-N,N-Dimethylacetamide for greener routes to known intermediates. These advances aren’t just theoretical: they link directly to cost savings, lower insurance premiums, and fewer regulatory headaches. From my time attending green chemistry expos and industry trade meetings, I’ve picked up countless discussions among engineers and procurement teams looking for these sorts of incremental improvements, not just headline-making breakthroughs. That kind of progress really moves the needle in the long run.
Chemists staring down a list of candidate reagents might start with spreadsheets and catalogs, but real-world performance counts the most. Compounds that sound interchangeable on paper often diverge in response to air, moisture, or complex molecular environments. 2-Bromo-N,N-Dimethylacetamide rarely creates surprises during storage or transfer; its relatively non-volatile nature and liquid state at room temperature avoid hassles linked to dusty solids or fuming liquids. Products with unstable halogens or complicated solubility profiles often add hidden costs—specialty shipment or required containment measures can eat away at profit margins and slow down experiments or production runs.
Using this compound instead of other brominated or chlorinated amides typically lowers incident reports in busy labs—accidental inhalation or contact incidents tend to drop, based on available industrial safety data. Waste management is also simpler, with fewer restrictions on spent solutions compared to heavier halogenated waste. These incremental benefits tally up quickly for teams working under constant time, cost, and audit pressures.
Complex synthesis targets reward predictable, repeatable results. A reagent that works seamlessly through pilot and into scale-up phases earns its place in any serious chemistry operation. Current feedback from bench researchers and plant managers matches my experience: compounds like 2-Bromo-N,N-Dimethylacetamide help teams hit project milestones, finish trials ahead of schedule, and keep downstream departments happy. Hidden bottlenecks seldom crop up because its behavior in process and in waste streams has already been worked out in peer-reviewed studies or past FDA dossiers.
Decisions that seem easy on paper—such as substituting a reagent—can snowball into real headaches at scale. Supply chain hiccups, new regulatory findings, or simple formulation quirks have derailed more than one project in my career. Hands-on familiarity counts. This is where trusted specialty chemicals like 2-Bromo-N,N-Dimethylacetamide have an edge. The predictability of handling, storage, and synthesis outcomes adds an element of stability that project managers, scientists, and regulatory reviewers all appreciate. Teams spend less time testing for batch-to-batch consistency and more time moving their ideas forward.
Many chemical operations rely on diverse teams—seasoned veterans, fresh-out-of-school researchers, and shift technicians. Each brings a different tolerance for complexity and risk. Over and over, I’ve watched projects succeed based not just on a single breakthrough, but on the reliability of everyday materials and workflow. Picking a reagent with a solid track record in both R&D and scale-up turns out to be a subtle but essential decision. In this context, 2-Bromo-N,N-Dimethylacetamide serves as an enabling tool, one that silently supports much larger scientific and industrial goals.
Modern synthesis isn’t just about getting from point A to B; it’s about minimizing risk, maximizing efficiency, and planning for audits, scalability, and sustainability. The right chemical choice can unlock new classes of reactions, provide safe passage across regulatory lines, and offer practical savings that can fund future research. 2-Bromo-N,N-Dimethylacetamide stands out as one of those compounds that, thanks to unique reactivity and versatile uses, fits this mold.
In conversations across R&D, procurement, and regulatory teams, I’ve seen a growing consensus that nimble, future-focused companies pick supporting reagents as carefully as main catalysts and active ingredients. Everyone in these supply chains understands the stakes. It’s easy to chase after only the flashiest breakthroughs, but experienced practitioners know that reliability—batch after batch, year after year—adds up to a competitive edge. While the compound won’t make headlines on its own, it drives innovation where it counts: in every successful synthesis, efficient waste stream, and passed audit. For chemists, engineers, and decision-makers, that’s a difference worth betting on.